The certification covers the company’s manufacturing facility for cephalosporin, carbapenem, and lyophilized injectable ...

Toripalimab, independently developed by Junshi Biosciences, is a monoclonal antibody targeting PD-1 for the treatment of multiple malignant tumors. To date, toripalimab has been approved for marketing ...

DONALD Trump this week warned the EU to buy more American oil and gas “otherwise, it’s TARIFFS all the way”. The social media post from the new US President is the latest in a series of threats to ...

The government will announce this afternoon whether it will agree to a halt on specific new EU laws requested under the ...

If the results from the clinical development plans are positive, it may well reflect a paradigm shift for clinical care.

EQS-News: Formycon AG / Key word (s): Regulatory Approval Formycon receives EU approval for FYB203 (aflibercept), a biosimilar to Eylea®, under the brand names AHZANTIVE® and Baiama® 20.01.2025 / ...

Shanghai-based Junshi Biosciences has announced a partnership with Denmark’s LEO Pharma to distribute and commercialise the ...

The past few years have been a roller coaster ride for M&A in pharma and biotech. After the highs of the pandemic came ...

© 2025 BBC. The BBC is not responsible for the content of external sites. Read about our approach to external linking.